Associations between Chinese Visceral Adiposity Index and the Risk of Metabolic Dysfunction-associated Steatotic Liver Disease and Liver Fibrosis: A Large Cross-sectional Study
Background: The associations between Chinese visceral adiposity index (CVAI) and non-alcoholic fatty liver disease (NAFLD) or hepatic fibrosis in Westerners are not obvious. Furthermore, metabolic dysfunction-associated steatotic liver disease (MASLD) is the new nomenclature of NAFLD, with significa...
Saved in:
Main Authors: | Hui Liu, Mingming Deng, Gang Luo, Jie Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Shiraz University of Medical Sciences
2025-01-01
|
Series: | Iranian Journal of Medical Sciences |
Subjects: | |
Online Access: | https://ijms.sums.ac.ir/article_50447_f20f0583bc64c7c5cb5fbea22e6c99da.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lymph Node Adiposity and Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Jessica M. Rubino, et al.
Published: (2025-01-01) -
Metabolic dysfunction-associated steatotic liver disease
by: Chieh Chen, et al.
Published: (2024-12-01) -
Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021
by: Gong Feng, et al.
Published: (2025-03-01) -
Evidence summary of lifestyle interventions in adults with metabolic dysfunction-associated steatotic liver disease
by: Mei-jing Chen, et al.
Published: (2025-01-01) -
Complement 3a receptor 1 on macrophages and Kupffer cells is not required for the pathogenesis of metabolic dysfunction-associated steatotic liver disease
by: Edwin A Homan, et al.
Published: (2025-01-01)